Bristol Myers Squibb application for subcutaneous Nivolumab validated by EMA Ruchika Sharma23 Jun 2024 10:00 AM ISTPrinceton: Bristol Myers Squibb has announced that the European Medicines Agency (EMA) has validated the extension application to introduce...
Bristol Myers Squibb gets USFDA accelerated approval for Krazati, Cetuximab combo for colorectal cancer Ruchika Sharma22 Jun 2024 11:11 AM ISTPrinceton: Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for...
USFDA approves Bristol Myers Squibb Augtyro for NTRK-Positive Locally Advanced or Metastatic Solid Tumors Ruchika Sharma15 Jun 2024 4:26 PM ISTPrinceton: Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval of...
Eli Lilly appoints Melissa Seymour as executive vice president of Global Quality Ruchika Sharma5 Jun 2024 11:30 AM ISTIndianapolis: Eli Lilly and Company has announced that Melissa Seymour will join the company as executive vice president of Global Quality and member...
Bristol Myers Squibb Breyanzi gets USFDA nod for Relapsed or Refractory Mantle Cell Lymphoma Ruchika Sharma31 May 2024 2:15 PM ISTPrinceton: Bristol Myers Squibb has announced the U.S. Food and Drug Administration (FDA) has granted approval for Breyanzi (lisocabtagene...
Bristol Myers Squibb gets European Commission nod for Opdivo in combo with cisplatin, gemcitabine for urothelial carcinoma Ruchika Sharma30 May 2024 12:49 PM ISTPrinceton: Bristol Myers Squibb has announced that the European Commission (EC) has approved Opdivo (nivolumab) in combination with...
BMS Gets CDSCO Panel Nod to Study Deucravacitinib Dr. Divya Colin20 May 2024 6:00 PM ISTNew Delhi: The drug major BMS has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation...
USFDA grants accelerated approval for Bristol Myers Squibb CAR T Cell Therapy Breyanzi for Relapsed or Refractory Follicular Lymphoma Ruchika Sharma16 May 2024 2:30 PM ISTPrinceton: Bristol Myers Squibb has announced the U.S. Food and Drug Administration (FDA) has granted accelerated approval for...
Dr Reddy's Labs expects strong product pipeline in North America for FY25 Ruchika Sharma9 May 2024 5:47 PM ISTBengaluru: Dr. Reddy's Laboratories, based in India, forecasts a strong product lineup for its key market in North America in the fiscal year...
EMA Committee recommends nod for Bristol Myers Squibb Opdivo in combination with Cisplatin, Gemcitabine for Urothelial Carcinoma Ruchika Sharma28 April 2024 11:30 AM ISTPrinceton: Bristol Myers Squibb has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines...
USFDA nod to Bristol Myers Squibb-2seventy bio Abecma for triple-class exposed relapsed or refractory Multiple Myeloma after 2 prior lines of therapy Ruchika Sharma8 April 2024 4:23 PM ISTPrinceton: Bristol Myers Squibb and 2seventy bio, Inc. have announced that the U.S. Food and Drug Administration (FDA) has approved...
Bristol Myers Squibb Reblozyl gets expanded European nod for anemia in lower risk Myelodysplastic Syndromes Ruchika Sharma4 April 2024 2:13 PM ISTPrinceton: Bristol Myers Squibb has announced that the European Commission (EC) has expanded approval of Reblozyl (luspatercept) to include...
